Target Delivery of a Novel Antitumor Organoplatinum(IV)-Substituted Polyoxometalate Complex for Safer and More Effective Colorectal Cancer Therapy In Vivo

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 28(2016), 34 vom: 01. Sept., Seite 7397-404
1. Verfasser: Sun, Tiedong (VerfasserIn)
Weitere Verfasser: Cui, Wei, Yan, Mei, Qin, Geng, Guo, Wei, Gu, Hongxi, Liu, Shaoqin, Wu, Qiong
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article antitumor activity micelles polyoxometalates target delivery Antineoplastic Agents Prodrugs Tungsten Compounds polyoxometalate I Cisplatin Q20Q21Q62J
LEADER 01000naa a22002652 4500
001 NLM261455915
003 DE-627
005 20231224195606.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201601778  |2 doi 
028 5 2 |a pubmed24n0871.xml 
035 |a (DE-627)NLM261455915 
035 |a (NLM)27309631 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sun, Tiedong  |e verfasserin  |4 aut 
245 1 0 |a Target Delivery of a Novel Antitumor Organoplatinum(IV)-Substituted Polyoxometalate Complex for Safer and More Effective Colorectal Cancer Therapy In Vivo 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 18.10.2018 
500 |a Date Revised 30.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a An inactive organoplatinum(IV)-substituted polyoxometalate is developed as an efficient and nontoxic prodrug with significant potential for treating human colorectal cancers. Further encapsulation of Pt(IV) -PW11 with DSPE-PEG2000 nanoparticles (NPs) enables targeted delivery and controlled release of inactive prodrug. Such Pt(IV) -PW11 -DSPE-PEG2000 NPs are highly efficient in inhibiting cellular growth of HT29 cells and treating human colorectal cancer in mice, superior to classic cisplatin 
650 4 |a Journal Article 
650 4 |a antitumor activity 
650 4 |a micelles 
650 4 |a polyoxometalates 
650 4 |a target delivery 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Prodrugs  |2 NLM 
650 7 |a Tungsten Compounds  |2 NLM 
650 7 |a polyoxometalate I  |2 NLM 
650 7 |a Cisplatin  |2 NLM 
650 7 |a Q20Q21Q62J  |2 NLM 
700 1 |a Cui, Wei  |e verfasserin  |4 aut 
700 1 |a Yan, Mei  |e verfasserin  |4 aut 
700 1 |a Qin, Geng  |e verfasserin  |4 aut 
700 1 |a Guo, Wei  |e verfasserin  |4 aut 
700 1 |a Gu, Hongxi  |e verfasserin  |4 aut 
700 1 |a Liu, Shaoqin  |e verfasserin  |4 aut 
700 1 |a Wu, Qiong  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 28(2016), 34 vom: 01. Sept., Seite 7397-404  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:28  |g year:2016  |g number:34  |g day:01  |g month:09  |g pages:7397-404 
856 4 0 |u http://dx.doi.org/10.1002/adma.201601778  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 28  |j 2016  |e 34  |b 01  |c 09  |h 7397-404